Frontiers in Pharmacology
Formononetin improved healthspan via the P53/P21/CDK4 pathway in SAMP8 mice and DAF-16/SKN-1 signaling pathway in C.elegans

Experiments in miceInterventions
5 months, dose-response, declared no competing interests
The paper
Zunyi Medical University
Frontiers in Pharmacology, 23 Sep 2026
